Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori eradication therapy with or without probiotics and effects on intestinal microbiota
ChiCTR-TRC-13003228Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esomeprazole, clarithromycin and amoxicillin in Helicobacter pylori infection and duodenal ulcer (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Intestinal microbiota. Started Dec 2012; status: completed.
02
Drugs
esomeprazoleclarithromycinamoxicillin
03
Conditions
Helicobacter pylori infectionduodenal ulcer
Beyond the preview
Go deeper on ChiCTR-TRC-13003228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003228.